Nabumetone Tablet
Product Images NDC 51655-733

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 51655-733). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 733 52 Master Bottle Label Approval Rev A 07 21)

This describes a medication named Nabumetone, which comes in the form of tablets. The container has 30 tablets, each containing 750mg of Nabumetone. The medicine is prescription-only and should be stored at temperatures between 20-25°C; excursions are permitted between 15-30°C. The container should be kept out of the reach of children and must be stored in its original container. The medicine is repackaged by Northwind Pharmaceuticals with a GTIN of 0035165733523. The lot number is 0000000000, with a manufacturing date of 00/00/0000.*

FDA Label Image

Figure1 (Figure1)

This is a graph showing Nabumetone Active Metabolite (BMNA) Plasma Concentrations at steady state following once-daily dosing of either 1000mg or 2000mg of Nabumetone. The graph has time duration plotted on the x-axis while the y-axis shows the concentration levels. The concentration levels were measured at various intervals for 31 participants who took 1000mg of Nabumetone and 12 participants who took 2000mg of Nabumetone.*

FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

6-methoxy-2-naphthylacetic acid (SMNA) is a chemical compound with the molecular formula COOH-CHgO.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.